Abstract:What's new Susceptibility genes already associated with nonsyndromic familial nonmedullary thyroid carcinoma (FNMTC) account for only a small portion of the disease's genetic burden. Hence, other predisposing genetic alterations are suspected. Here, the authors applied next‐generation sequencing to analyze cancer‐predisposing genes in probands from families with FNMTC. Analyses uncovered multiple genes relevant to FNMTC etiology, including genes involved in DNA repair, where variants are likely to disturb protein–protein interactions. Moreover, three germline variants were found in DICER1, a gene already incorporated into clinical practice for assessing thyroid neoplasia predisposition. The findings broaden the genetic landscape of FNMTC and cast light on pathways for therapeutic targeting. The genetic basis of nonsyndromic familial nonmedullary thyroid carcinoma (FNMTC) is still poorly understood, as the susceptibility genes identified so far only account for a small percentage of the genetic burden. Recently, germline mutations in DNA repair‐related genes have been reported in cases with thyroid cancer. In order to clarify the genetic basis of FNMTC, 94 genes involved in hereditary cancer predisposition, including DNA repair genes, were analyzed in 48 probands from FNMTC families, through targeted next‐generation sequencing (NGS). Genetic variants were selected upon bioinformatics analysis and in silico studies. Structural modeling and network analysis were also performed. In silico results of NGS data unveiled likely pathogenic germline variants in 15 families with FNMTC, in genes encoding proteins involved in DNA repair (ATM, CHEK2, ERCC2, BRCA2, ERCC4, FANCA, FANCD2, FANCF, and PALB2) and in the DICER1, FLCN, PTCH1, BUB1B, and RHBDF2 genes. Structural modeling predicted that most missense variants resulted in the disruption of networks of interactions between residues, with implications for local secondary and tertiary structure elements. Functional annotation and network analyses showed that the involved DNA repair proteins functionally interact with each other, within the same DNA repair pathway and across different pathways. MAPK activation was a common event in tumor progression. This study supports that rare germline variants in DNA repair genes may be accountable for FNMTC susceptibility, with potential future utility in patients' clinical management, and reinforces the relevance of DICER1 in disease etiology.

Identification of P21 (CDKN1A) Activated Kinase 4 as a susceptibility gene for Familial Non-medullary Thyroid Carcinoma

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer

Identification of a Novel Germline PPP4R3A Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

Whole Exome and Target Sequencing Identifies MAP2K5 As Novel Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma

Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer

A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer

Exploring Somatic Alteration Associating With Aggressive Behaviors of Papillary Thyroid Carcinomas by Targeted Sequencing

Targeted Next Generation Sequencing Identifies Somatic Mutations and Gene Fusions in Papillary Thyroid Carcinoma

Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer

Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways

Identification and Validation of a Prognostic Signature for Thyroid Cancer Based on Ferroptosis-Related Genes.

Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies

PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer

Genetic alterations in cfDNA of benign and malignant thyroid nodules based on amplicon-based next-generation sequencing

Transcriptomic Signature Associated with Carcinogenesis and Aggressiveness of Papillary Thyroid Carcinoma

The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing

TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway

Identification of LINC02454-related key pathways and genes in papillary thyroid cancer by weighted gene coexpression network analysis (WGCNA)

EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices

Clinical Significance of Papillary Thyroid Cancer Risk Loci Identified by Genome-Wide Association Studies.